首頁 > 市場調查報告書 > 醫療設備

器官移植市場規模、佔有率和成長分析（按產品類型、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1898685

器官移植市場規模、佔有率和成長分析（按產品類型、應用、最終用途和地區分類）－2026-2033年產業預測

Transplantation Market Size, Share, and Growth Analysis, By Product Type (Tissue Products, Immunosuppressive Drugs), By Application (Organ Transplantation, Tissue Transplantation), By End-Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球器官移植市場規模將達到 168.5 億美元，到 2025 年將達到 183.5 億美元，到 2033 年將達到 363 億美元，預測期（2026-2033 年）的複合年成長率為 8.9%。

全球器官移植市場受人口老化和生活方式改變導致的器官衰竭和慢性疾病（包括腎衰竭、肝衰竭和心臟衰竭）盛行率上升的驅動。外科手術技術、免疫抑制劑和組織工程技術的進步顯著提高了移植成功率，並改善了患者的預後。然而，手術複雜性、高昂的費用以及對專業醫療基礎設施的需求等挑戰限制了器官移植的普及。市場成長的機會包括開發創新技術，例如用於器官保存的機械灌注技術，以及副作用較少的新型免疫抑制劑。提高公眾對器官捐贈的認知以及加強醫療機構間的策略合作，有助於解決器官短缺問題，促進更多人獲得挽救生命的移植服務，並提高患者的生活品質。

全球移植市場促進因素

末期腎功能衰竭、肝硬化、心臟衰竭和呼吸系統疾病等慢性病的日益普遍，顯著推高了器官移植的需求。糖尿病及其併發症等疾病的顯著增加，進一步推動了腎臟和胰臟移植的需求。隨著越來越多的患者患有這些慢性病，醫療系統面臨著擴大移植服務以滿足其迫切需求的壓力，這也推動了全球移植市場的成長。這項轉變凸顯了有效的器官移植在改善患者預後和應對醫療危機的重要角色。

限制全球移植市場的因素

全球器官移植市場面臨嚴峻挑戰，器官移植費用高昂，包括移植前評估、手術、術後照護、長期免疫抑制劑治療等。這些經濟負擔給患者、醫療系統和保險公司都帶來了沉重壓力。此外，移植服務的保險覆蓋範圍和報銷政策的限制，進一步加劇了這些關鍵手術的成本效益和可及性問題。這些因素共同抑制了整個移植市場的發展，導致許多患者無法獲得所需的器官移植，儘管移植手術可能挽救他們的生命。

全球移植市場趨勢

全球移植市場日益關注精準醫療，其目標是透過根據個別患者特徵量身定做治療方法來提高移植療效。利用生物標記分析、基因檢測和先進的診斷工具，醫療服務提供者可以最佳化免疫抑制治療，從而改善患者的整體預後。這種向個人化的轉變正在推動移植通訊協定的重組、相容性評估的加強以及移植後併發症管理的改進。隨著醫療系統將精準醫療方法置於優先地位，預計行業相關人員將增加對創新技術和研究的投資，最終推動患者照護的進步並提高移植成功率。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

AbbVie Inc.（USA）
BioLife Solutions（USA）
Medtronic（USA）
Arthrex, Inc.（USA）
Zimmer Biomet（USA）
21st Century Medicine（USA）
Novartis AG（Switzerland）
Stryker（USA）
Teva Pharmaceutical Industries Ltd.（Israel）
Veloxis Pharmaceuticals, Inc.（USA）
TransMedics Inc.（USA）
Hoffmann-La Roche Ltd.（Switzerland）
Astellas Pharma Inc.（Japan）
Preservation Solutions, Inc.（USA）
OrganOx Limited（UK）
Terumo Corporation（Japan）
Transonic（USA）
Sanofi（France）
Pfizer Inc.（USA）
CareDx, Inc.（USA）

結論與建議

簡介目錄

Product Code: SQMIG35D2158

Global Transplantation Market size was valued at USD 16.85 Billion in 2024 and is poised to grow from USD 18.35 Billion in 2025 to USD 36.3 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The global transplantation market is driven by the rising prevalence of organ failure and chronic diseases such as kidney, liver, and heart conditions, fueled by aging populations and lifestyle changes. Technological advancements in surgical techniques, immunosuppressive medications, and tissue engineering have significantly improved transplant success rates, enhancing patient outcomes. However, challenges like the complexity of procedures, high costs, and the need for specialized healthcare infrastructure can limit access. Opportunities for market growth include innovative methods like machine perfusion for organ preservation and the development of novel immunosuppressive drugs with fewer side effects. Increased awareness of organ donation and strategic collaborations among healthcare organizations can address organ shortages, ensuring broader access to life-saving transplantation services and fostering improved quality of life for patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segments Analysis

Global Transplantation Market is segmented by Product Type, Application, End-Use and region. Based on Product Type, the market is segmented into Tissue Products, Immunosuppressive Drugs and Preservation Solutions. Based on Application, the market is segmented into Organ Transplantation and Tissue Transplantation. Based on End-Use, the market is segmented into Hospitals, Transplant Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplantation Market

The increasing prevalence of chronic illnesses, including end-stage renal disease, liver cirrhosis, heart failure, and respiratory disorders, is significantly driving the need for organ transplantation. A notable surge in conditions like diabetes and its associated complications has particularly intensified the demand for kidney and pancreas transplants. As more individuals face the challenges posed by these chronic diseases, healthcare systems are being compelled to expand their transplantation services to meet the urgent needs of patients, thereby fostering growth within the global transplantation market. This shift underscores the critical role of effective organ transplantation in enhancing patient outcomes and addressing the healthcare crisis.

Restraints in the Global Transplantation Market

The global transplantation market faces considerable challenges due to the high costs associated with organ transplants, which encompass pre-transplant assessments, surgical procedures, postoperative care, and long-term immunosuppressive medications. These financial demands create substantial burdens for patients, healthcare systems, and insurance companies. Additionally, the limitations in insurance coverage and reimbursement policies for transplantation services exacerbate issues related to affordability and access to these critical procedures. This combination of factors contributes to the overall restraint of the transplantation market, making it difficult for many individuals to obtain necessary organ transplants despite potential life-saving benefits.

Market Trends of the Global Transplantation Market

The global transplantation market is increasingly characterized by a growing emphasis on precision medicine, which seeks to enhance the efficacy of transplant therapies by tailoring them to individual patient profiles. By leveraging biomarker analysis, genetic testing, and sophisticated diagnostic tools, healthcare providers can optimize immunosuppressive treatments and improve overall patient outcomes. This shift towards personalization is reshaping transplantation protocols, enhancing compatibility assessments, and facilitating better management of post-transplant complications. As healthcare systems prioritize precision approaches, stakeholders across the industry are likely to invest in innovative technologies and research, ultimately driving advancements in patient care and increasing the success rates of transplant procedures.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Transplantation Market Size by Product Type & CAGR (2026-2033)

Market Overview
Tissue Products
Immunosuppressive Drugs
Preservation Solutions

Global Transplantation Market Size by Application & CAGR (2026-2033)

Market Overview
Organ Transplantation
Tissue Transplantation

Global Transplantation Market Size by End-Use & CAGR (2026-2033)

Market Overview
Hospitals
Transplant Centers
Others

Global Transplantation Market Size & CAGR (2026-2033)

North America (Product Type, Application, End-Use)
- US
- Canada
Europe (Product Type, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arthrex, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
21st Century Medicine (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Veloxis Pharmaceuticals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TransMedics Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Preservation Solutions, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OrganOx Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transonic (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareDx, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments